All Supplement articles
View all stories of the same content type.
-
SupplementProstap® DCS (leuprorelin acetate)—a 3-monthly gonadotrophin-releasing hormone (GnRH) agonist treatment for breast cancer
Information intended for UK healthcare professionals only. This round-table discussion supplement has been commissioned and funded by Takeda UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
C-APROM/UK/PRS/0152
Date of preparation: April 2021 -
Supplement
Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care
This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice.
View Trajenta® (linagliptin) prescribing and adverse event reporting information
PC-GB-103451 Date of preparation: January 2021 -
Supplement
The re-usable Respimat® Soft Mist inhaler
This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
PC-GB-103142 November 2020 -
Supplement
Real-world usage study and survey of oral bowel cleansing for colonoscopy in Dudley, UK
This supplement has been commissioned by Norgine Pharmaceuticals Limited and contains promotional information. Information for healthcare professionals only.
Click here for PLENVU® (macrogol 3350, sodium ascorbate, ascorbic acid, sodium sulfate anhydrous, potassium chloride, sodium chloride) Prescribing and Adverse Event Reporting.
Click here for MOVIPREP® ((macrogol 3350, sodium sulfate anhydrous, ascorbic acid, sodium ascorbate, sodium chloride, and potassium chloride) Prescribing and Adverse Event Reporting.
Click here for KLEAN-PREP (macrogol 3350, anhydrous sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride) Prescribing and Adverse Event Reporting.
UK-GE-PLV-2000027
Date of preparation: February 2021 -
Supplement
Recommending emollients for patients with atopic dermatitis or dry skin conditions
This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines.
Date of preparation: January 2021 -
Supplement
Practical tips for maintaining asthma care prompted by a supply issue during the COVID-19 pandemic
This supplement has been commissioned and funded by Glenmark Pharmaceuticals Europe Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
PP-UK-SOP-0129 December 2020 -
Supplement
Showcasing local best practice in diabetes
This Guidelines in Practice supplement aims to showcase local best practice in the diagnosis and management of diabetes. The supplement includes articles from three local initiatives that have developed their own guidance or demonstrated improvements in different areas of diabetes care: Dr David Unwin shares ...
-
Supplement
Diabetes quality improvement at Barking and Dagenham: closing the inequalities gap
Dr Anju Gupta and Richard Clements explain how improvements in the quality of diabetes care were achieved, and variation reduced, in a socioeconomically deprived London borough
-
Supplement
Local, evidence-based guidance: optimising treatment of type 2 diabetes in Birmingham
Professor Wasim Hanif, Dr Nashat Qamar, and Hanadi Alkhder discuss the need for local guidance on non-insulin antidiabetic agents for adults with type 2 diabetes, and the important role played by the multidisciplinary team
-
Supplement
Successful dietary management of type 2 diabetes: experience from Norwood Surgery in Southport
Dr David Unwin shares details of how a GP practice in Liverpool has supported patients to achieve drug-free type 2 diabetes remission through dietary management
-
Supplement
An optimised patient pathway for the treatment of heterosexual patients with infertility
This supplement has been commissioned and funded by Merck Serono Ltd and developed in partnership with Guidelines in Practice.
-
Supplement
Identification and management of patients with malnutrition
This supplement has been commissioned and funded by Alliance Pharmaceuticals Ltd and developed in partnership with Guidelines in Practice.
-
Supplement
Guideline for the managed introduction of biosimilar basal insulin
This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.
